Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Sleep More, Stress Less with Neuralli Mood

Official title: Effects of Neuralli Mood Probiotic Supplementation on Stress, Sleep Disturbance, Mood, and Burnout: A 90-Day Single-Arm Study

Run by Efforia, Inc · NCT07717385 · Data updated 2026-11-12

This 90-day, open-label study tests whether daily Neuralli Mood capsules can help adults feel less stressed, sleep better, and improve mood and burnout symptoms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorEfforia, Inc
Industry-sponsored
Locations1 site (New York, New York)
StatusRecruiting
StartedJune 30, 2026
Main results expectedSeptember 28, 2027
Study endsSeptember 28, 2027
Registry record updatedJuly 21, 2026
Trial IDNCT07717385 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with self-reported stress or sleep disruption, low mood, anxiety symptoms, or work-related burnout, willing to take Neuralli Mood daily for 90 days and complete online assessments.

Probably not a fit

People with severe or unstable mood disorders, significant sleep disorders requiring medical management, or those with contraindicating health conditions may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This exploratory, decentralized, single-arm study enrolls adults experiencing stress or sleep disruption to take two Neuralli Mood capsules daily for 90 days. Participants serve as their own controls by completing validated questionnaires before starting and after 90 days to measure perceived stress, sleep quality, mood, anxiety, depressive symptoms, happiness, and burnout, with safety and adherence checks throughout. Neuralli Mood contains probiotic and postbiotic gut-brain strains (L. plantarum PS128 and heat-treated L. paracasei PS23) administered as 30 billion CFU and 20 billion non-viable cells per day. The study design is prospective and open-label, without a concurrent control group, and aims to generate preliminary, individualized before-and-after information while acknowledging potential placebo and self-selection effects.

Why it matters

Potential benefit: If successful, participants might experience reductions in stress and burnout and improvements in sleep and mood.

How similar studies have gone: Previous probiotic- or gut-brain-axis–focused studies have shown signals of mood and sleep benefits, but high-quality evidence remains limited and this study is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older and able to provide informed consent.
* Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.
* Willing and able to take two capsules of Neuralli Mood daily for 90 days.
* Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.
* Has reliable access to the internet and an email-enabled device.

Exclusion Criteria:

* Pregnant or nursing.
* Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.
* Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.
* Immunocompromised status or current immunosuppressive therapy.
* Severe or unstable mood disorder, acute psychiatric symptoms, or a current risk of harm to self or others.
* A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional.
* Cognitive impairment or another condition that prevents informed consent or reliable completion of study procedures.
* History of a severe allergic reaction when the investigator determines probiotic use may present an unacceptable risk.
* Use of a medication or presence of a medical condition for which a healthcare professional advises against probiotic supplementation.
* Any other circumstance that, in the investigator's judgment, makes participation inappropriate or unsafe.

Where it's running

  • Efforia - Decentralized United States Study
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.